Verofylline

This classification denotes a bronchodilator with the molecular formula C12H18N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1J8O1GT31U, chemically known as 3,7-dihydro-1,8-dimethyl-3-(2-methylbutyl)-1h-purine-2,6-dione but generally known as verofylline, which bears US NIH Compound Identifier 47845. European Medicines Agency schedules Verofylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00042MIG. The term VEROFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). VEROFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule verofylline under HS 29335995 and SITC 51576. As of Q4 2014, VEROFYLLINE remains the US FDA Preferred Term for this commodity. Verofylline bears US NLM identifiers UMLS ID C0148324 and NCI Concept Code C96193. SMILES: CCC(C)CN1C2=C(C(=O)N(C1=O)C)NC(=N2)C.